Skip to Content

BMS 213 (Daklinza 30 mg)

Generic Name: daclatasvir

Pill with imprint BMS 213 is Green, Five-sided and has been identified as Daklinza 30 mg. It is supplied by Bristol-Myers Squibb Company.

Daklinza is used in the treatment of hepatitis c and belongs to the drug class NS5A inhibitors. Daklinza 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for BMS 213

Daklinza

Generic Name:
daclatasvir
Imprint:
BMS 213
Strength:
30 mg
Color:
Green
Shape:
Five-sided
Availability:
Prescription only
Drug Class:
NS5A inhibitors
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb Company
National Drug Code (NDC):
00003-0213

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide